SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc. (Nasdaq:APPX) announced today that, in response to FDA and hospital concerns about a potential shortage of therapeutic heparin, it will immediately increase manufacturing of the critical therapeutic heparin multi-dose vials. Customers with inquiries may contact APP customer service at 888-386-1300 and will be directed to a “Heparin Hotline” specialist.
